Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Cancer

Explore clinical trials studying Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

1,289 public trials 284 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Cancer trial results

Completed

PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)

NCT04484636

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +28 more
Locations
  • KHNW Frankfurt Frankfurt am Main, Hesse, Germany
  • Hannover Medical School Hanover, Lower Saxony, Germany
  • Onkologische Schwerpunktpraxis Speyer Speyer, Rhineland-Palatinate, Germany
  • Elblandklinikum Riesa Ried, Saxony, Germany
View all 46 locations
View Trial Details
Completed

Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma

NCT01601808

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • The Royal Bournemouth Hospital Bournemouth, United Kingdom
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Royal Surrey County Hospital Guildford, United Kingdom
View all 14 locations
View Trial Details
Completed

PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine

NCT05697198

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +68 more
Locations
  • Clinical Site Fort Payne, Alabama, United States
  • Clinical Site Orange City, Florida, United States
  • Clinical Site Stuart, Florida, United States
  • Clinical Site Dublin, Georgia, United States
View Trial Details
Completed

A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6

NCT03058289

Conditions
Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +51 more
Locations
  • USC Norris Los Angeles, California, United States
  • USC HOAG Newport Beach, California, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • UMASS Memorial Medical Center Worcester, Massachusetts, United States
View Trial Details
Completed

Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America

NCT05924789

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +12 more
Locations
  • Instituto de Oncología San Gerónimo Santa Fe, Santa Fe Province, Argentina
  • ÉTICA Clínica AMO - Assistência Multidisciplinar em Oncologia Salvador, Estado de Bahia, Brazil
  • HMV - Hospital Moinhos de Vento Porto Alegre, Rio Grande do Sul, Brazil
  • CEPON - Centro de Pesquisas Oncológicas Florianópolis, Santa Catarina, Brazil
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901

NCT04805307

Conditions
Advanced Solid Tumor, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations
  • Sun Yat-sen University Cancer Center (SYSUCC) Guangzhou, Guangdong, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • West China Hospital of Sichuan University Chengdu, Sichuan, China
  • Affiliated Hospital of Hebei University Baoding, China
View all 32 locations
View Trial Details
Completed

LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors

NCT04666688

Conditions
Bile Duct Diseases, Bile Duct Neoplasms, Biliary Tract Diseases, +32 more
Locations
  • UCLA Los Angeles, California, United States
  • University of Colorado Hospital Denver, Colorado, United States
  • Sarah Cannon Research Institute at Health One Denver, Colorado, United States
  • Sarah Cannon Research Institute, Florida Cancer Specialists Sarasota, Florida, United States
View Trial Details
Completed

LY3214996 +/- HCQ in Pancreatic Cancer

NCT04386057

Conditions
Advanced Cancer, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details

Related conditions